Tag: 7

新加坡, July 10, 2025 (GLOBE NEWSWIRE) -- 新成立的特殊目的收购公司 Origin Investment Corp I （以下简称“本公司”）今日宣布已完成其首次公开募股 (“IPO”)，本次发行共计 6,000,000 个单位，发行价格为每单位 10.00 美元。每个单位包括一股普通股和二分之一份可赎回认股权证。 该等单位自 2025 年 7 月 2 日起在纳斯达克全球市场 (Nasdaq Global Market)（以下简称“Nasdaq”）挂牌交易，股票代码为 “ORIQU”。 每份完整的认股权证赋予持有人以每股 11.50 美元的价格认购一股普通股的权利，且该价格可根据招股说明书中的相关条款进行调整。 仅可整份行使认股权证。 认股权证将在公司完成首次业务合并后 30 天起可供行使，并将在公司完成首次业务合并后五年到期，或在赎回或公司清算时提前到期。 待组成首次公开募股单位的各项证券开始分开交易后，普通股和认股权证预计将分别在Nasdaq交易，交易代码分别为“ORIQ”和“ORIQW”。 在发行单位分拆后，公司不会发行非整份认股权证，且仅整份认股权证可供交易。 此外，公司已授予承销商一项为期 45 天的超额配售期权，承销商可按首次公开募股价格额外购买最多 900,000 个发行单位（如有超额配售）。

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the XPLR Infrastructure class action lawsuit seeks to represent purchasers or acquirers of XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP (NYSE: XIFR) securities between September 27, 2023 and January 27, 2025, inclusive (the “Class Period”). Captioned Alvrus v. XPLR Infrastructure, LP f/k/a NextEra Energy Partners, LP, No. 25-cv-01755 (S.D. Cal.), the XPLR Infrastructure class action lawsuit charges XPLR Infrastructure, NextEra Energy, Inc., and certain of XPLR Infrastructure’s top former executives with violations of the Securities Exchange Act of 1934.

Investors can contact the law firm at no cost to learn more about recovering their losses

MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA¹ PET² imaging agent, Gozellix® (kit for the preparation of gallium-68 (⁶⁸Ga) gozetotide injection), has been granted a permanent Healthcare Common Procedure Coding System (HCPCS) code by the U.S. Centers for Medicare & Medicaid Services (CMS).

Experience Seamless Crypto Mining with DRML Miner

Discover DRML Miner: A Smarter Way to Mine Crypto